NecstGen is built upon a rich history of developments and innovations in regenerative medicine. Today Leiden’s ecosystem of academic and industrial partners continues to pioneer in research and the development of new regenerative therapies.

NecstGen

The Leiden office specializes in cell therapy and viral vector research, focusing on quality control and scientific innovation.

Leiden

Melissa Van Pel

Kinga Nowicka

Lindsay Mulder

Diederik Lokhorst

Marten Visser

Óscar Bártulos

This department focuses on the development, implementation, and management of cell therapy treatments and technologies.

Cell Therapy

The Research and Development team at NecstGen focuses on advancing regenerative medicine through innovative research and the development of cutting-edge therapies. Comprising experts in cell therapy and viral vector technology, the team conducts scientific investigations, ensures biosafety standards, and collaborates with academic and industrial partners to translate groundbreaking discoveries into effective treatments for patients.

Research and Development

This department ensures products meet established quality standards through testing and analysis.

Quality Assurance

This department focuses on the development and application of viral vector technologies for various scientific and therapeutic purposes.

Viral Vector Operations

This department focuses on collecting and analyzing data related to environmental conditions to ensure compliance and quality standards.

Environmental Monitoring

This department is responsible for overseeing and executing maintenance and repair tasks to ensure the functionality and safety of facilities.

NecstGen

Org chart

Teams

Cell Therapy

Research and Development

Quality Assurance

Viral Vector Operations

Environmental Monitoring

Facility Maintenance

Offices

NecstGen

Org chart

Teams

Cell Therapy

Research and Development

Quality Assurance

Viral Vector Operations

Environmental Monitoring

Facility Maintenance

Offices

Related companies